FunPep

•  March 4,2024
•  Press Release

Announcement of Option Agreement between FunPep and SHIONOGI Regarding Allergy Vaccine

[PDF file]

•  November 27,2023
•  Press Release

Notice Concerning Commencement of Research on Alzheimer’s Disease Vaccine

[PDF file]

•  August 24,2023
•  Press Release

Exercise of Option by MEDIPAL HOLDINGS CORPORATION

[PDF file]

•  June 13,2023
•  Press Release

Announcement of Newly Developed Compound for Antibody-Inducing Peptide against Pollinosis

[PDF file]

•  February 14,2023
•  Press Release

Announcement of Preliminary Results of Phase I/IIa Clinical Trial of Antibody Inducing Peptide FPP003

[PDF file]

•  November 22,2022
•  Press Release

Announcement of Preliminary Results for the Phase III Clinical Trial of Functional Peptide SR-0379

[PDF file]

•  October 17,2022
•  Press Release

Notice of Business Transfer to Consolidated Subsidiary

[PDF file]

•  August 18,2022
•  Press Release

Exercise of Option by MEDIPAL HOLDINGS CORPORATION

[PDF file]

•  July 25,2022
•  Press Release

Notice of Completion of Subject Enrollment in Phase III Clinical Trial of Functional Peptide SR-0379

[PDF file]

•  June 6,2022
•  Press Release

Notice Concerning the Completion of Subject Enrollment for the Phase I/IIa Clinical Study of Antibody-Inducing Peptide FPP003

[PDF file]